Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Pharmacy Innovations

Pharmacy Innovations Recalls

All product recalls associated with Pharmacy Innovations.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

1000

Class I (Serious)

127

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 4981–5000 of 25000 recalls

Magnesium Chloride (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Hydroxocobalamin Injectable (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Vancomycin Ophthalmic Solution (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class II

1...248 249250251 252...1250

Page 250 of 1250Next

Moderate

FDADec 22, 2022Nationwide• Pharmacy Innovations

5-Fluorouracil (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

PE1/Papaverine Combination Injectable (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Methylcobalamin Injection (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Phosphatidylcholine/Deoxycholic Acid (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Methotrexate Intravitreal Injectable (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Phenol Injection (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

NADH Injectable (Pharmacy Innovations) – sterility concerns (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Glycerin Injectable (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Edetate Calcium Disodium (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Mitomycin Ophthalmic Solution (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Glycerin Lidocaine Injection (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Albuterol Inhalation Solution (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Tacrolimus Ophthalmic Solution (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Gentamicin Bladder Irrigation (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Dexamethasone (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Lidocaine Injectable (Pharmacy Innovations) – sterility concern (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations

Vitamin D3 (Pharmacy Innovations) – Sterility Risk (2022)

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class IIModerate

FDADec 22, 2022Nationwide• Pharmacy Innovations